Orexo AB Total Assets

Latest as of June 2026: Skr514.60 Million SEK ≈ $55.38 Million USD

Orexo AB total assets. Based on the latest financial reports, Orexo AB (ORX) holds total assets worth Skr514.60 Million SEK (≈ $55.38 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Orexo AB (ORX) market capitalisation for the company's overall valuation and market capitalisation.

Total Assets of Orexo AB (2002–2025)

Total assets of Orexo AB from 2002 to 2025. This chart illustrates how Orexo AB's total assets have evolved over time, based on quarterly financial data. See ORX live share price for real-time trading data and today's change.

Orexo AB - Asset Composition Analysis

Orexo AB Total Assets Breakdown (December 2025)

Orexo AB total assets breakdown as of December 2025. Orexo AB's total assets of Skr514.60 Million consist of 89.4% current assets and 10.6% non-current assets.

Asset Category	Amount (SEK)	% of Total Assets
Cash & Equivalents	Skr0.00	70.0%
Accounts Receivable	Skr228.30 Million	17.5%
Inventory	Skr0.00	0.0%
Property, Plant & Equipment	Skr56.40 Million	4.3%
Intangible Assets	Skr400.00K	0.0%
Goodwill	Skr0.00	0.0%

Asset Composition Trend (2002–2025)

This chart illustrates how Orexo AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital position of Orexo AB to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Orexo AB's current assets represent 89.4% of total assets in 2025, an increase from 61.1% in 2002.
Cash Position: Cash and equivalents constituted 70.0% of total assets in 2025, up from 44.7% in 2002.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 29.0% in 2002.
Asset Diversification: The largest asset category is accounts receivable at 17.5% of total assets.

Orexo AB Competitors by Total Assets

Key competitors of Orexo AB based on total assets are shown below.

Company	Country	Total Assets
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	China	CN¥9.54 Billion
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	China	CN¥6.44 Billion
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	China	CN¥1.54 Billion
Renhe Pharmacy Co Ltd SHE:000650	China	CN¥7.93 Billion
Bide Pharmatech Co. Ltd. A SHG:688073	China	CN¥2.54 Billion
Jianmin Pharmaceutical Group Co Ltd SHG:600976	China	CN¥4.69 Billion
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	China	CN¥2.26 Billion
Shenzhen Neptunus Bioengineering Co Ltd SHE:000078	China	CN¥25.73 Billion

Orexo AB - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.65	1.48	2.50
Quick Ratio	1.65	1.32	2.24
Cash Ratio	0.00	0.00	0.00
Working Capital	Skr149.90 Million	Skr120.50 Million	Skr536.30 Million

Orexo AB - Advanced Valuation Insights

This section examines the relationship between Orexo AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.86
Latest Market Cap to Assets Ratio	0.00
Asset Growth Rate (YoY)	119.0%
Total Assets	Skr1.30 Billion
Market Capitalization	$5.66 Million USD

Valuation Analysis

Below Book Valuation: The market values Orexo AB's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Orexo AB's assets grew by 119.0% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Orexo AB (2002–2025)

The table below shows the annual total assets of Orexo AB from 2002 to 2025.

Year	Total Assets	Change
2025-12-31	Skr1.30 Billion ≈ $140.20 Million	+119.03%
2024-12-31	Skr594.80 Million ≈ $64.01 Million	-24.38%
2023-12-31	Skr786.60 Million ≈ $84.65 Million	-29.07%
2022-12-31	Skr1.11 Billion ≈ $119.35 Million	-12.93%
2021-12-31	Skr1.27 Billion ≈ $137.07 Million	+3.31%
2020-12-31	Skr1.23 Billion ≈ $132.68 Million	-17.87%
2019-12-31	Skr1.50 Billion ≈ $161.54 Million	+16.66%
2018-12-31	Skr1.29 Billion ≈ $138.47 Million	+28.17%
2017-12-31	Skr1.00 Billion ≈ $108.04 Million	-1.46%
2016-12-31	Skr1.02 Billion ≈ $109.64 Million	+0.25%
2015-12-31	Skr1.02 Billion ≈ $109.37 Million	-17.10%
2014-12-31	Skr1.23 Billion ≈ $131.92 Million	+58.73%
2013-12-31	Skr772.33 Million ≈ $83.12 Million	+60.32%
2012-12-31	Skr481.75 Million ≈ $51.84 Million	-11.78%
2011-12-31	Skr546.10 Million ≈ $58.77 Million	-23.37%
2010-12-31	Skr712.69 Million ≈ $76.70 Million	+9.76%
2009-12-31	Skr649.33 Million ≈ $69.88 Million	-7.51%
2008-12-31	Skr702.02 Million ≈ $75.55 Million	-12.45%
2007-12-31	Skr801.87 Million ≈ $86.29 Million	+111.06%
2006-12-31	Skr379.93 Million ≈ $40.89 Million	+2.32%
2005-12-31	Skr371.31 Million ≈ $39.96 Million	+250.24%
2004-12-31	Skr106.02 Million ≈ $11.41 Million	+134.80%
2003-12-31	Skr45.15 Million ≈ $4.86 Million	+35.80%
2002-12-31	Skr33.25 Million ≈ $3.58 Million	--

About Orexo AB

ST:ORX Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$5.66 Million

Skr52.62 Million SEK

Market Cap Rank

#28257 Global

#619 in Sweden

Share Price

Skr1.50

Change (1 day)

-64.38%

52-Week Range

Skr1.50 - Skr35.75

All Time High

Skr85.70